SIRT6 and neoplasm: Given that Sirt6 has already been established as a potent tumor suppressor by several independent studies (Lerrer and Cohen, 2013; Sebastián et al., 2012), this explains as to why Sirt6-/-Trp53+/- mice exhibit an earlier onset of tumorigenesis and mostly develop tumors other than sarcoma.